Sign in

or Register now

MultipleSclerosisCentral.com

    See all of our health sites at www.HealthCentral.com
    Saturday, November 21, 2009
    • Font size
    • Bookmark
    • Save
    Receive a FREE Osteoarthritis of the knee pamphlet. Start here.

    FDA panel backs MS drug

    (Reuters) UPDATED 2009-10-19
    A U.S. Food and Drug Administration (FDA) panel has recommended approval of the MS drug fampridine. The panel said the drug appears to be safe and effective, but they warned that patients who had seizure problems should not take the medication. The FDA is due to make a decision on the drug on October 22, but experts say it may be delayed until early 2010.  Read full story >
    See all Multiple Sclerosis News
    • Font size
    • Bookmark
    • Was this helpful? Yes
    • Save

    People who read this also read...

      Note: All clinical content on this site is physician-reviewed, except material generated by our community members.
      Featuring Content From:
      • Harvard Health Publications
      • A.D.A.M.
      • Thomson PDR
      • Ivanhoe Broadcast News

      By using this service, you accept our Terms of Use. Please read them. The consumer health information on MultipleSclerosisCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

      This website is accredited by Health On the Net Foundation. Click to verify.We comply with the HONcode standard for trustworthy health information: verify here.
      • TRUSTe Certified Privacy
      • Health Care Standard of Excellence
      • FREDDIE International Health and Medical Media Award Finalist